BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?

Core Viewpoint - BrightSpring Health Services, Inc. (BTSG) is expected to report a year-over-year increase in earnings and revenues for the quarter ended June 2025, with a consensus EPS estimate of $0.19, reflecting a 90% increase, and revenues projected at $2.99 billion, up 9.4% from the previous year [1][3]. Earnings Expectations - The stock price may rise if the actual earnings exceed expectations in the upcoming report, scheduled for August 1, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised 3.68% higher in the last 30 days, indicating a positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative Earnings ESP reading indicates the likely deviation of actual earnings from the consensus estimate, with a positive reading being a strong predictor of an earnings beat [9][10]. - For BrightSpring, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -8.11%, suggesting a bearish outlook [12]. Historical Performance - BrightSpring has beaten consensus EPS estimates in two out of the last four quarters, with a notable surprise of +137.50% in the last reported quarter [14][15]. Industry Comparison - CVS Health, a competitor in the Zacks Medical Services industry, is expected to report an EPS of $1.47, reflecting a year-over-year decrease of 19.7%, with revenues projected at $93.72 billion, up 2.7% [20]. - CVS Health has a positive Earnings ESP of +2.06% and a Zacks Rank of 2, indicating a likely earnings beat, having surpassed consensus EPS estimates in the last four quarters [20][21].